Docket Room
HB 3357·MO·house

Prohibits the sale of intravenous solution containers and intravenous tubing products intentionally made with DEHP

FailedFiled Feb 19, 2026
Sponsor: Jeremy Dean
Latest Action

Referred: Emerging Issues(H)

May 15, 2026

Summary

The bill would prohibit manufacturers and sellers in Missouri from offering intravenous solution containers and tubing that contain DEHP added on purpose. It sets compliance dates of January 1, 2030 for containers and January 1, 2035 for tubing, limits any unintentional DEHP to less than 0.1% by weight, and exempts certain blood‑collection devices. The aim is to lower patient exposure to the chemical.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when HB 3357 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice